AXIM BIOTECHNOLOGIES, INC. Quarterly Return On Assets in % from Q4 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Axim Biotechnologies, Inc. quarterly/annual Return On Assets history and growth rate from Q4 2012 to Q2 2024.
  • Axim Biotechnologies, Inc. Return On Assets for the quarter ending June 30, 2024 was -105 %, a 52.9% increase year-over-year.
  • Axim Biotechnologies, Inc. annual Return On Assets for 2023 was -196 %, a 43.4% decline from 2022.
  • Axim Biotechnologies, Inc. annual Return On Assets for 2022 was -137 %, a 12.2% increase from 2021.
  • Axim Biotechnologies, Inc. annual Return On Assets for 2021 was -156 %, a 176% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -105 +117 +52.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -137 +23.6 +14.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -196 -59.3 -43.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -171 +106 +38.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -222 -20.9 -10.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -160 +36.9 +18.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -137 +19.1 +12.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -276 -188 -214% Jul 1, 2022 Sep 30, 2022
Q2 2022 -201 -121 -152% Apr 1, 2022 Jun 30, 2022
Q1 2022 -197 -151 -330% Jan 1, 2022 Mar 31, 2022
Q4 2021 -156 -99.2 -176% Oct 1, 2021 Dec 31, 2021
Q3 2021 -88 -27.1 -44.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -79.8 -12.2 -18% Apr 1, 2021 Jun 30, 2021
Q1 2021 -45.8 +91.5 +66.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -56.4 +202 +78.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -60.9 +170 +73.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -67.7 +227 +77% Apr 1, 2020 Jun 30, 2020
Q1 2020 -137 +247 +64.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -259 +355 +57.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -231 +409 +63.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -294 +133 +31.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 -385 -147 -61.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -614 -459 -296% Oct 1, 2018 Dec 31, 2018
Q3 2018 -641 -484 -310% Jul 1, 2018 Sep 30, 2018
Q2 2018 -428 -223 -109% Apr 1, 2018 Jun 30, 2018
Q1 2018 -238 +302 +55.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -155 +454 +74.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -156 +1.05K +87% Jul 1, 2017 Sep 30, 2017
Q2 2017 -205 +825 +80.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -540 +75.8 +12.3% Jan 1, 2017 Mar 31, 2017
Q4 2016 -609 +19.1 +3.04% Oct 1, 2016 Dec 31, 2016
Q3 2016 -1.21K -925 -328% Jul 1, 2016 Sep 30, 2016
Q2 2016 -1.03K -827 -409% Apr 1, 2016 Jun 30, 2016
Q1 2016 -616 -404 -190% Jan 1, 2016 Mar 31, 2016
Q4 2015 -628 -503 -400% Oct 1, 2015 Dec 31, 2015
Q3 2015 -282 -196 -228% Jul 1, 2015 Sep 30, 2015
Q2 2015 -202 +19.6 +8.86% Apr 1, 2015 Jun 30, 2015
Q1 2015 -212 -89.2 -72.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -126 -29 -30% Oct 1, 2014 Dec 31, 2014
Q3 2014 -85.9 -57.2 Jul 1, 2014 Sep 30, 2014
Q2 2014 -222 -190 -591% Apr 1, 2014 Jun 30, 2014
Q1 2014 -123 -106 -637% Jan 1, 2014 Mar 31, 2014
Q4 2013 -96.5 -79.3 -460% Oct 1, 2013 Dec 31, 2013
Q3 2013 -28.7* Jul 1, 2013 Sep 30, 2013
Q2 2013 -32.1 Apr 1, 2013 Jun 30, 2013
Q1 2013 -16.7 Jan 1, 2013 Mar 31, 2013
Q4 2012 -17.2 Oct 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.